Your monthly Aliqopa cost savings if eligible
With our assistance, you could access the Aliqopa patient assistance program and obtain your medication for free. We only charge a flat monthly fee of $49 per medication for our services.
Am I eligible for Aliqopa patient assistance?
We review each Aliqopa enrollment application individually to determine if you are eligible. Each assistance program has its own eligibility criteria and the factors considered by most programs are:
- I am a permanent, legal resident of the United States or Puerto Rico
- I am uninsured or my insurance doesn’t cover my medication
- I meet certain income eligibility requirements
How do I apply for the Aliqopa patient assistance program?
Our process makes it as easy as possible to apply for the Aliqopa patient assistance program. Begin by completing the enrollment application form on our website. Tell us about any medications that you are taking, including Aliqopa, your healthcare provider, your insurance plan, and your household income. This information is required by the pharmaceutical manufacturers who will supply the medication, so it is important to make sure this information is accurate and up to date.
We will review the information that you have provided to determine whether you are eligible for patient assistance. If we can pre-qualify you for assistance, NiceRx will handle the full enrollment process on your behalf. If you are approved by the pharmaceutical company, you will typically start receiving your medication in 6 – 8 weeks.
Is NiceRx an Aliqopa coupon provider?
NiceRx is not an Aliqopa coupon, Aliqopa discount card, or Aliqopa copay card provider. We do not offer Aliqopa manufacturer coupons, Aliqopa discounts, rebates, Aliqopa savings cards, trial offers, or free Aliqopa samples. We are a service provider that helps eligible individuals access their medication directly from the U.S. pharmaceutical company.
Can NiceRx help me get Aliqopa cheaper if I have insurance?
NiceRx may be able to help you if:
- You have a high copay or coinsurance responsibility for Aliqopa
- Your insurance company will not pay for your Aliqopa prescription
- Your healthcare plan does not cover your medication
- You do not have insurance
Please apply online to find out if we can help you.
How much does Aliqopa cost without insurance?
Without insurance, Aliqopa costs will vary depending on where you buy the medication as prices will vary by retailer. As a guide, Aliqopa intravenous powder for injection 60 mg will cost around $5,100 for 1 powder for injection.
How much does Aliqopa cost with insurance?
The copay for Aliqopa will depend on the terms of your healthcare plan. Your healthcare provider or pharmacist will be able to calculate your copay with your current insurance. Contact them to find out more.
What is Aliqopa?
Aliqopa is an FDA (U.S. Food and Drug Administration) approved medication manufactured by Bayer HealthCare Pharmaceuticals, Inc. It is a kinase inhibitor indicated for the treatment of adult patients with relapsed follicular lymphoma (FL) who have received at least two prior systemic therapies. Follicular lymphoma is a slow-growing type of B-cell non-Hodgkin lymphoma, a cancer of the lymph system. Aliqopa works by blocking several enzymes that promote cancer cell growth.
Accelerated approval was granted for this indication based on the overall response rate. Continued approval for this indication may be contingent upon verification and description of clinical benefit in a confirmatory trial.
What doses of Aliqopa are available?
Aliqopa is available in injection form, in the following doses: 60 mg as a lyophilized solid in a single-dose vial for reconstitution.
The recommended dosage is 60 mg administered as a 1-hour intravenous infusion on Days 1, 8, and 15 of a 28-day treatment cycle. See the full prescribing information for important preparation and administration information and always speak with a healthcare professional about any changes to your dose so they can monitor and evaluate your condition.
Aliqopa active ingredients
The active ingredient of Aliqopa is copanlisib. It is a Pan class I phosphatidylinositol-3-kinase inhibitor (PI3K inhibitor) with a mechanism of action against PI3K-alpha and PI3K-delta isoforms expressed in malignant B cells. By inhibiting several key cell-signaling pathways it may induce apoptosis and stop the spread of premalignant B cells and in turn, cause tumor cell death.
Aliqopa side effects
The most common side effects of Aliqopa in clinical trials include:
In rare instances, Aliqopa can cause more serious side effects. These can include:
- Lower respiratory tract infections
- Hyperglycemia – start each infusion once optimal blood glucose control is achieved
- Hypertension – withhold treatment in patients until the systolic blood pressure (BP) is less than 150 mmHg and the diastolic BP is less than 90 mmHg
- Non-infectious pneumonitis
- Neutropenia – monitor blood counts
- Leukopenia (reduced white blood cells)
- Severe cutaneous reactions
- Embryo-fetal toxicity – use effective contraception
Your doctor will assess the benefits of using Aliqopa against your risk of side effects. Patients are encouraged to report negative side effects or adverse reactions of Aliqopa to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.
Aliqopa drug interactions
Aliqopa can interact with other medications. These include:
- Strong CYP3A inducers
- CYP3A inhibitors
- Rifamycins such as rifabutin
- St. John’s wort
- Drugs used to treat seizures such as carbamazepine, phenytoin
This list is not exhaustive and other prescription drugs may interact with Aliqopa.
You should not use Aliqopa if you:
- Are allergic to the active ingredient copanlisib
- Are allergic to any of the other ingredients in Aliqopa
- Are pregnant or are planning to become pregnant – use effective contraception during treatment and for at least 1 month after the last dose
- Are breastfeeding or are planning to breastfeed – do not breastfeed during treatment and for at least 1 month after the last dose
Talk to your doctor before using Aliqopa if you:
- Are taking any of the medications that could interact with Aliqopa
- Have liver disease
- Have an infection
- Have lung disease or breathing problems
- Have high blood pressure
- Have diabetes
Aliqopa is the trademark brand name for copanlisib manufactured by Bayer HealthCare Pharmaceuticals, Inc. A generic version of copanlisib is not available. Generic drugs are generally cheaper than brand-name drugs, but you can still find Aliqopa savings through NiceRx.
The content on this website is intended for information purposes only. It does not constitute medical advice. The information on this website should not be relied upon and is not a substitute for professional medical advice. You should always speak to your doctor regarding the risks and benefits of any treatment.